Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Preface to the First Edition | p. v |
Preface to the Second Edition | p. vii |
Introduction | p. xiii |
Antibodies | |
[alpha]-Smooth Muscle Actin ([alpha]-SMA) | p. 3 |
[alpha]-1-antichymotrypsin | p. 5 |
[alpha]-1-antitrypsin | p. 7 |
[alpha]-Fetoprotein (AFP) | p. 11 |
Amyloid | p. 13 |
Androgen receptor | p. 17 |
Anti-apoptosis | p. 19 |
Anti-p80 (ALK-NMP fusion protein) | p. 23 |
Bcl-2 | p. 25 |
Bcl-6 | p. 29 |
Ber-EP4 | p. 31 |
[beta]-hCG (Human Chorionic Gonadotropin) | p. 33 |
CA 125 | p. 35 |
N/97-Cadherin/E-Cadherin | p. 37 |
Calcitonin | p. 41 |
Calponin | p. 43 |
Calretinin | p. 45 |
Candida Albicans | p. 49 |
Carcinoembryonic Antigen (CEA) | p. 51 |
Catenins, [alpha], [beta], [gamma] | p. 53 |
Cathepsin D | p. 55 |
CD 1 | p. 59 |
CD 2 | p. 61 |
CD 3 | p. 63 |
CD 4 | p. 65 |
CD 5 | p. 67 |
CD 7 | p. 71 |
CD 8 | p. 73 |
CD 9 | p. 75 |
CD 10 (CALLA) | p. 77 |
CD 103 | p. 79 |
CD 11 | p. 81 |
CD 15 | p. 83 |
CD 19 | p. 87 |
CD 20 | p. 89 |
CD 21 | p. 93 |
CD 23 | p. 95 |
CD 24 | p. 97 |
CD 30 (Ki-1) | p. 99 |
CD 31 | p. 103 |
CD 34 | p. 105 |
CD 35 | p. 109 |
CD 38 | p. 111 |
CD 40 | p. 113 |
CD 43 | p. 115 |
CD 44 | p. 117 |
CD 45 (Leucocyte Common Antigen) | p. 121 |
CD 54 (ICAM-1) | p. 125 |
CD 56 (Neural Cell Adhesion Molecule) | p. 127 |
CD 57 | p. 131 |
CD 68 | p. 135 |
CD 74 (LN2) | p. 139 |
CD w75 (LN1) | p. 141 |
CD 79a | p. 143 |
CD99 (p30/32[superscript MIC2]) | p. 145 |
CD117 (KIT) | p. 149 |
c-erbB-2 (Her-2, neu) | p. 153 |
Chlamydia | p. 157 |
Chromogranin | p. 159 |
c-Myc | p. 161 |
Collagen Type IV | p. 163 |
Cyclin D1 (bcl-1) | p. 165 |
Cytokeratins | p. 167 |
Cytokeratin 20 (CK 20) | p. 171 |
Cytokeratin 7 (CK 7) | p. 173 |
Cytokeratins-MNF 116 | p. 175 |
Cytokeratins-CAM 5.2 | p. 177 |
Cytokeratins-AE1/AE3 | p. 179 |
Cytokeratins-MAK-6 | p. 181 |
Cytokeratins-34[beta]E12 | p. 183 |
Cytokeratin 5/6 (CK 5/6) | p. 185 |
Other Pan-cytokeratin Cocktails | p. 187 |
Cytomegalovirus (CMV) | p. 189 |
Cytotoxic Molecules (TIA-1, Granzyme B, Perforin) | p. 191 |
DBA.44 (Hairy Cell Leukemia) | p. 195 |
Desmin | p. 197 |
Desmoplakins | p. 201 |
Epidermal Growth Factors: TGF-[alpha] AND EGFR | p. 203 |
Epithelial Membrane Antigen (EMA) | p. 205 |
Epstein-Barr Virus, LMP | p. 209 |
Erythropoietin | p. 213 |
Estrogen Receptor (ER) | p. 215 |
Factor VIII RA (von Willebrand factor) | p. 219 |
Factor XIIIa | p. 221 |
Fas (CD95) and Fas-ligand (CD95L) | p. 223 |
Fascin | p. 225 |
Ferritin | p. 227 |
Fibrin | p. 229 |
Fibrinogen | p. 231 |
Fibronectin | p. 233 |
FLI-1 protein | p. 235 |
FMC-7 | p. 237 |
Glial Fibrillary Acidic Protein (GFAP) | p. 239 |
Gross Cystic Disease Fluid Protein-15 (GCDFP-15, BRST-2) | p. 241 |
HAM56 (Macrophage marker) | p. 245 |
HBME-1 (Mesothelial Cell) | p. 247 |
h-Caldesmon | p. 249 |
Heat shock proteins (Hsps) | p. 251 |
Helicobacter pylori | p. 253 |
Hep Par 1 (Hepatocyte marker) | p. 255 |
Hepatitis B Core Antigen (HBcAG) | p. 257 |
Hepatitis B Surface Antigen (HBsAG) | p. 259 |
Herpes Simplex Virus I & II (HSV I & II) | p. 261 |
HLA-DR | p. 263 |
HMB-45 (Melanoma marker) | p. 265 |
hMLH1 and hMSH2 - Mismatch repair proteins | p. 269 |
Human Immunodeficiency Virus (HIV) | p. 273 |
Human Milk Fat Globule (HMFG) | p. 275 |
Human Papilloma Virus (HPV) | p. 277 |
Human Parvovirus B19 | p. 279 |
Human Placental Lactogen (hPL) | p. 281 |
Immunoglobulins: Ig[kappa], Ig[lambda], IgA, IgD, IgE, IgG, IgM | p. 283 |
Inhibin | p. 287 |
Ki-67 (MIB 1, Ki-S5) | p. 289 |
Laminin | p. 293 |
Lysozyme (muramidase) | p. 297 |
MAC 387 (Macrophage marker) | p. 299 |
MART-1/Melan-A | p. 301 |
Maspin | p. 303 |
MDM-2 protein | p. 305 |
Measles | p. 307 |
Mel-CAM (CD146) | p. 309 |
Metallothioneins | p. 311 |
Micropthalmia transcription factor (MiTF) | p. 313 |
Mitochondria | p. 315 |
MOC-31 | p. 317 |
Muscle Specific Actin (MSA) | p. 319 |
Mycobacterial Antigen | p. 321 |
Myelin Basic Protein (MBP) | p. 323 |
Myeloperoxidase | p. 325 |
MyoD1 | p. 327 |
Myogenin | p. 331 |
Myoglobin | p. 333 |
Neurofilaments | p. 335 |
Neuron-Specific Enolase (NSE) | p. 337 |
Neutrophil elastase | p. 339 |
nm23/NME1 | p. 341 |
Osteopontin | p. 345 |
P27[superscript kip1] | p. 347 |
p53 | p. 349 |
Pancreatic Hormones (insulin, somatostatin, vasoactive intestinal polypeptide, gastrin, glucagon, pancreatic polypeptide) | p. 351 |
Parathyroid Hormone-Related Protein (PTHrP) | p. 357 |
Parathyroid hormone | p. 361 |
P-glycoprotein (P-170), Multi-Drug Resistance (MDR) | p. 363 |
Pituitary Hormones (ACTH, FSH, HGH, LH, PRL, TSH) | p. 365 |
Placental Aklaline Phosphatase (PLAP) | p. 369 |
Pneumocystis carinii | p. 371 |
Pregnancy-specific [beta]-1-glycoprotein (SP1) | p. 373 |
Progesterone Receptor (PR) | p. 375 |
Proliferating Cell Nuclear Antigen (PCNA) | p. 377 |
Prostate-Specific Antigen (PSA) | p. 379 |
Prostatic Acid Phosphatase (PAP) | p. 381 |
Protein Gene Product 9.5 (PGP 9.5) | p. 383 |
pS2 | p. 385 |
Rabies | p. 387 |
Retinoblastoma Gene Protein (P110[superscript RB], Rb protein) | p. 389 |
S100 | p. 391 |
Serotonin | p. 395 |
Simian Virus 40 (SV40 T antigen) | p. 397 |
Smooth muscle myosin-heavy chain | p. 399 |
Spectrin/Fodrin | p. 401 |
Surfactant apoprotein-A | p. 403 |
Synaptophysin | p. 405 |
TAG 72 (B72.3) | p. 407 |
Tau | p. 409 |
Tenascin | p. 411 |
Terminal Deoxynucleotidyl Transferase (TdT) | p. 413 |
Thrombomodulin | p. 417 |
Thyroglobulin | p. 419 |
Thyroid Transcription Factor-1 (TTF-1) | p. 421 |
Topoisomerase Ilalpha | p. 425 |
Toxoplasma gondii | p. 427 |
Tyrosinase | p. 429 |
Ubiquitin | p. 431 |
Ulex Europaeus Agglutinin 1 Lectin (UEA-I) | p. 433 |
VEGF (Vascular Endothelial Growth Factor) | p. 435 |
Villin | p. 437 |
Vimentin | p. 439 |
Vinculin | p. 443 |
VS38 | p. 445 |
WT1 | p. 447 |
Appendices | |
Selected antibody panels for specific diagnostic situations | p. 451 |
Bone/Soft tissue - Chondroid-like Tumors | p. 453 |
Brain - Metastatic Carcinoma vs Glioblastoma vs Meningioma | p. 453 |
Childhood Round Cell Tumors | p. 453 |
Gastrointestinal and Aerodigestive Tract Mucosa - Basaloid Squamous vs Adenoid Cystic vs Neuroendocrine Carcinoma | p. 453 |
Gonads - Germ Cell Tumors versus Somatic Adenocarcinoma | p. 454 |
Granulocytic sarcoma versus lymphoma versus carcinoma versus plasmacytoma | p. 454 |
Intracranial Tumors | p. 454 |
Liver - Hepatocellular Carcinoma vs Metastatic Carcinoma vs Cholangiocarcinoma | p. 454 |
Lung - Clear Cell Tumors | p. 455 |
Lymph Node - Round Cell Tumors in Adults | p. 455 |
Undifferentiated Round Cell Tumors | p. 455 |
Mediastinal tumors | p. 455 |
Nasal Tumors | p. 456 |
Pelvis - Metastatic Colonic Adenocarcinoma vs Ovarian Endometrioid Carcinoma | p. 456 |
Perineum - Prostatic vs Bladder vs Rectal Carcinoma | p. 456 |
Peritoneum - Myxoid Tumors | p. 456 |
Pleura - Mesothelioma vs Carcinoma | p. 457 |
Retroperitoneum - Renal Cell Carcinoma vs Adrenocortical Carcinoma vs Pheochromocytoma | p. 457 |
Retroperitoneum - Vacuolated/Clear Cell Tumor | p. 457 |
Skin - Adnexal Tumors | p. 457 |
Skin - Basal Cell Carcinoma vs Squamous Carcinoma vs Adnexal Carcinoma | p. 458 |
Skin - Pagetoid Tumors | p. 458 |
Skin - Spindle Cell Tumors | p. 458 |
Soft Tissue - Epithelioid Tumors | p. 459 |
Soft Tissue - Spindle Cell, fasciculated | p. 459 |
Soft Tissue - Myxoid Tumors | p. 459 |
Soft Tissue - Pleomorphic Tumors | p. 460 |
Extraskeletal Myxoid/Chondroid Tumors | p. 460 |
Stomach - Undifferentiated Spindle Cell Tumors | p. 460 |
Thyroid carcinomas | p. 460 |
Urinary Tract - Spindle Cell Proliferations | p. 461 |
Uterine cervix - Endometrial versus Endocervical Carcinoma | p. 461 |
Uterus - Trophoblastic Cells | p. 461 |
Uterus - Immunophenotyping of Syncytiotrophoblasts in Trophoblastic Proliferations | p. 462 |
Brain Intraventricular Tumors | p. 462 |
CNS Small Cell Tumors | p. 462 |
Tissue-Associated Antigens in "Treatable Tumors" | p. 463 |
Epithelial Tumors Which May Coexpress Vimentin Intermediate Filaments* | p. 463 |
Mesenchymal Tumors which may Coexpress Cytokeratin | p. 464 |
Tumors which may co-express three or more intermediate filaments | p. 464 |
Abbreviations to antibodies and their sources | p. 465 |
Antibody Panels for Lymphoid Neoplasms | p. 467 |
Useful Markers in B-cell Neoplasms | p. 467 |
Useful Markers of T-cell Neoplasms | p. 467 |
Markers of Reed Sternberg cells* | p. 468 |
Useful markers of Monocytes/macrophages | p. 468 |
Markers of Myeloid Cells | p. 468 |
Useful Markers of Natural Killer- (NK) cells | p. 469 |
Markers of langerhans Cells and Interdigitating Reticulum Cells | p. 469 |
Markers of Follicular Dendric Cells | p. 469 |
Panel for Small Cell Lymphomas | p. 469 |
Classic Hodgkin's Disease vs Lymphocyte Predominant Hodgkin's Disease vs T-cell/histiocyte-rich B-cell Lymphoma | p. 470 |
Antibody Applications | p. 471 |
Suppliers | |
Suppliers | p. 479 |
Table of Contents provided by Syndetics. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.